Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-005666
Filing Date
2019-01-28
Accepted
2019-01-28 18:54:33
Documents
1
Period of Report
2019-01-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3913
  Complete submission text file 0001209191-19-005666.txt   5311
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Levy Howard (Reporting) CIK: 0001672333 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51173 | Film No.: 19546788